Economic evaluation of glycoprotein IIb/IIIa inhibitors in patients undergoing percutaneous coronary intervention with stenting

He was responsible for the analysis in the review of economic literature and the sensitivity analysis. [...] She was responsible for the design and execution of the literature search strategies; for writing the methods section and the associated appendix on literature searching; and for verifying and formatting bibliographic references. [...] Decision analytic therapy and “scaffold-like” coronary stents modelling was done to estimate the short-term and embedded in the artery wall at the time of the PCI long-term cost-effectiveness of the two drugs. [...] CV diseases accounted for 18% of all hospitalizations among men and women in Canada in 2000-2001, a higher percentage than that of any other health problem.1 The number of elderly people in the Canadian population has been increasing and so has the number of deaths due to stroke and ischemic heart disease. [...] As these therapies were part of the standard pre- and post-treatments in all the relevant clinical trials, we decided to stay focused on the impact of the GP inhibitors for this study.